LIBRE LIFE LATEST NEWS

Abbott employees, a former Eli Lilly scientist, a healthcare lawyer and a university researcher have all appeared around Love My Libre. As Abbott challenges the Libreband trade mark, we ask whether these really are unrelated coincidences.

New research analysing almost 47 million CGM readings reveals how often glucose reaches a sensor's measurement limits, how long it can remain there and what that means for the information we see.

Apple is reportedly exploring a screenless health and fitness band that could compete with wearables such as Whoop. Recent events show how this increasing trend has a curious link to our own products

Abbott and Google plan one of the largest real-world metabolic health studies to date, with consumers buying the sensors and supplying the health data that builds AI they won't own. This isn't simply about Lingo: it could shape the future of CGM, who controls the intelligence behind our glucose data and ultimately how diabetes is managed.

Summer 2026 has brought important developments across FreeStyle Libre, from Libre 3 Plus and rapid growth in hybrid closed-loop use to new ADA evidence supporting Libre Duo, AI-powered Libre Assist and Abbott's wider move into connected health.

A research smart ring can monitor glucose and ketones from sweat continuously. It's an exciting step, but it remains a long way from replacing CGMs.

FDA Commissioner Martin Makary recently highlighted the role of CGMs in preventing chronic conditions, questioning why they are only available on prescription. Could there be any benefit to the diabetes community of a policy change?

New medtech startup, Luna Health, based in the US, have raised $23.6 million to advance a patch pump designed specifically for overnight use only.